Skip to Content

CardieX Ltd AMDHF

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

CardieX Ltd is a global health technology company, developing solutions for health disorders. Its AtCor Medical division develops and markets products for the early detection of target organ damage and management of a cardiovascular and renal disease. The company has three reportable segments by geographic area namely the Americas includes, global pharmaceutical trials business, Europe includes, the Middle East and Africa and the Asia Pacific includes, Asia & Australia/New Zealand.

Contact
15 Lime Street, Suite 303, Level 3
Sydney, NSW, 2000, Australia
T +61 298748761
Sector Healthcare
Industry Medical Devices
Most Recent Earnings
Fiscal Year End Jun 30, 2020
Stock Type
Employees 27